Want to see CI full AI Analyst Report?
CI Stock Chart & Stats
$278.64
-$1.43(-0.51%)
At close: 4:00 PM EST
$278.64
-$1.43(-0.51%)
Day’s Range― - ―
52-Week Range$239.51 - $338.89
Previous CloseN/A
Volume191.22K
Average Volume (3M)1.55M
Market Cap
$73.29B
Enterprise Value$99.28B
Total Cash (Recent Filing)$7.85B
Total Debt (Recent Filing)$30.90B
Price to Earnings (P/E)11.7
Beta0.24
Next Earnings
Jul 30, 2026EPS Estimate
7.57Next Dividend Ex-DateN/A
Dividend Yield2.21%
Share Statistics
EPS (TTM)23.72
Shares Outstanding264,532,400
10 Day Avg. Volume1,452,658
30 Day Avg. Volume1,550,689
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.75
Price to Sales (P/S)0.27
P/FCF Ratio8.73
Enterprise Value/Market Cap1.35
Enterprise Value/Revenue0.36
Enterprise Value/Gross Profit3.84
Enterprise Value/Ebitda8.14
Forecast
1Y Price Target
$341.94Price Target Upside22.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)30.45
Revenue Forecast (FY)$284.92B
Bulls Say, Bears Say
Bulls Say
Scale & Diversified Revenue BaseCigna’s very large, diversified revenue base across insurance and health services produces meaningful absolute earnings and free cash flow, supporting reinvestment, dividends and buybacks. Size and product diversity reduce single-product risk and support durable contract leverage versus peers.
Evernorth Specialty & Care MomentumRobust specialty and care-services growth reflects structural demand for specialty drugs and care management, driving higher-margin service lines. This mix shift supports sustainable earnings and offsets broader PBM commoditization, strengthening long-term service revenue quality.
Planned CEO Succession With ContinuityA planned, internal CEO transition preserves strategic continuity and institutional knowledge while signaling governance stability. Promoting an experienced internal operator reduces execution risk on multi-year initiatives like PBM transformation and digital/AI rollouts.
Bears Say
Multi-year Margin CompressionDeclining gross and EBITDA margins constrain operating leverage and make earnings more sensitive to medical cost trends and pricing dynamics. Sustained margin erosion could limit capital returns and raises the bar for future efficiency or product mix improvements to restore profitability.
PBS Earnings Pressure & Transition RiskA sizeable drop in Pharmacy Benefit Services earnings and an ongoing shift to a rebate-free model create near- and medium-term revenue and margin uncertainty. Client renewals, contract economics and transition costs could persistently pressure PBM cash flow and complicate long-term margin recovery.
Cash Flow Timing And FCF Growth WeaknessWhile absolute FCF is sizable, recent negative FCF growth and H2-weighted cash generation add timing risk to capital allocation. Seasonal or lumpy cash flows reduce near-term financial flexibility for buybacks or M&A and make liquidity management more sensitive to adverse operating shocks.
CI FAQ
What was Cigna’s price range in the past 12 months?
Cigna lowest stock price was $239.51 and its highest was $338.89 in the past 12 months.
What is Cigna’s market cap?
Cigna’s market cap is $73.29B.
When is Cigna’s upcoming earnings report date?
Cigna’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were Cigna’s earnings last quarter?
Cigna released its earnings results on Apr 30, 2026. The company reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.598 by $0.192.
Is Cigna overvalued?
According to Wall Street analysts Cigna’s price is currently Undervalued.
Does Cigna pay dividends?
Cigna pays a Quarterly dividend of $1.56 which represents an annual dividend yield of 2.21%. See more information on Cigna dividends here
What is Cigna’s EPS estimate?
Cigna’s EPS estimate is 7.57.
How many shares outstanding does Cigna have?
Cigna has 264,532,400 shares outstanding.
What happened to Cigna’s price movement after its last earnings report?
Cigna reported an EPS of $7.79 in its last earnings report, beating expectations of $7.598. Following the earnings report the stock price went down -0.595%.
Which hedge fund is a major shareholder of Cigna?
Currently, no hedge funds are holding shares in CI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cigna Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$341.94 (22.72% Upside)
$341.94 (22.72% Upside)
Blogger Sentiment
Bullish
CI Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $268.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.30%
12-Months-Change
Fundamentals
Return on Equity
15.16%
Trailing 12-Months
Asset Growth
1.99%
Trailing 12-Months
Company Description
Cigna
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
CI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: consolidated revenue and EPS growth, a raised full-year EPS outlook, robust specialty and Cigna Healthcare performance, and meaningful innovation (rebate-free pharmacy model and AI-enabled savings). Primary headwinds centered on near-term PBS earnings pressure (28% decline) due to renewals and transition investments, a material special-items charge ($322M after-tax), and portfolio exits/strategic reviews that reduce near-term scope. Management presented these challenges as deliberate and manageable trade-offs to sharpen focus and accelerate long-term value creation.View all CI earnings summariesCI Stock 12 Month Forecast
Average Price Target
$341.94
▲(22.72% Upside)
Technical Analysis
Ownership Overview
0.35% Insiders
28.19% Mutual Funds
<0.01% Other Institutional Investors
47.24% Public Companies and Individual Investors













